News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
263,861 Results
Type
Article (13696)
Company Profile (100)
Press Release (250065)
Section
Business (88003)
Career Advice (464)
Deals (15339)
Drug Delivery (66)
Drug Development (36572)
Employer Resources (49)
FDA (6279)
Job Trends (6193)
News (150137)
Policy (14021)
Tag
Academia (437)
Alliances (23195)
Alzheimer's disease (375)
Approvals (6301)
Artificial intelligence (86)
Bankruptcy (146)
Best Places to Work (4370)
Breast cancer (69)
Cancer (501)
Cardiovascular disease (52)
Career advice (406)
Cell therapy (72)
Clinical research (30724)
Collaboration (273)
Compensation (114)
COVID-19 (753)
C-suite (90)
Data (497)
Diabetes (66)
Diagnostics (1308)
Drug discovery (46)
Drug pricing (60)
Earnings (31773)
Events (37162)
Executive appointments (309)
FDA (6593)
Funding (171)
Gene therapy (84)
GLP-1 (320)
Government (1278)
Healthcare (3551)
Infectious disease (780)
Inflammatory bowel disease (52)
Interviews (58)
IPO (5868)
Job creations (2050)
Job search strategy (372)
Layoffs (175)
Legal (3426)
Lung cancer (71)
Manufacturing (122)
Medical device (1268)
Medtech (1270)
Mergers & acquisitions (9612)
Metabolic disorders (210)
Neuroscience (519)
NextGen: Class of 2025 (1585)
Non-profit (592)
Northern California (600)
Obesity (122)
Opinion (116)
Patents (86)
People (28740)
Pharmaceutical (64)
Phase I (7997)
Phase II (12997)
Phase III (11663)
Pipeline (272)
Policy (52)
Postmarket research (1401)
Preclinical (3187)
Radiopharmaceuticals (117)
Rare diseases (141)
Real estate (2632)
Regulatory (9992)
Research institute (563)
Resumes & cover letters (55)
Southern California (594)
Startups (1625)
United States (5947)
Vaccines (132)
Weight loss (88)
Date
Today (30)
Last 7 days (229)
Last 30 days (1044)
Last 365 days (12375)
2025 (1722)
2024 (12499)
2023 (14246)
2022 (19556)
2021 (20068)
2020 (19032)
2019 (14885)
2018 (11713)
2017 (13888)
2016 (13129)
2015 (15472)
2014 (12419)
2013 (10592)
2012 (11395)
2011 (11922)
2010 (10888)
Location
Africa (312)
Arizona (46)
Asia (19994)
Australia (2588)
California (1431)
Canada (790)
China (185)
Colorado (60)
Connecticut (61)
Europe (39149)
Florida (250)
Illinois (165)
Indiana (113)
Japan (72)
Kansas (53)
Maryland (212)
Massachusetts (1214)
Minnesota (78)
New Jersey (608)
New York (404)
North Carolina (340)
Northern California (600)
Pennsylvania (360)
South America (500)
Southern California (594)
Texas (185)
Virginia (57)
Washington State (99)
263,861 Results for "supernus pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Depression
Supernus Falls Back on CNS Portfolio as Depression Drug Fails Mid-Stage Study
After SPN-820’s failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s therapy Onapgo to sustain the company.
February 20, 2025
·
2 min read
·
Tristan Manalac
BioCapital
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
Supernus Pharmaceuticals, Inc. announced today that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1:30 p.m. ET at the Marriott Marquis Hotel in New York City.
May 30, 2024
·
4 min read
Press Releases
Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results
February 12, 2025
·
1 min read
Press Releases
Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
February 18, 2025
·
4 min read
Press Releases
Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference
November 14, 2024
·
4 min read
Press Releases
Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease
February 4, 2025
·
14 min read
Parkinson’s disease
Supernus Taps Potential $300M US Opportunity With FDA Win for Parkinson’s Drug-Device Combo
Before garnering approval on Tuesday, Onapgo had been rejected twice by the FDA.
February 5, 2025
·
2 min read
·
Tristan Manalac
BioCapital
Supernus to Participate in Two Upcoming March 2024 Investor Conferences
Supernus Pharmaceuticals, Inc. announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will participate in the following March investor conferences:
March 6, 2024
·
4 min read
Business
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
Supernus Pharmaceuticals, Inc. announced that it expects to report financial and business results for the first quarter of 2024 after the market closes on Wednesday, May 8, 2024.
April 24, 2024
·
1 min read
Business
Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
August 28, 2024
·
3 min read
1 of 26,387
Next
